A 28-year-old woman at 12 weeks gestation is diagnosed with a complete hydatidiform mole. Which nursing intervention is the priority following dilation and curettage (D&C) procedure?

Following D&C for hydatidiform mole, the priority is emphasizing reliable contraception for at least 12 months to prevent pregnancy during beta-hCG monitoring for malignant transformation. Other interventions are important but less urgent.

Understanding the Clinical Scenario

The scenario describes a 28-year-old woman at 12 weeks gestation diagnosed with a complete hydatidiform mole (CHM), a form of gestational trophoblastic disease (GTD). Her presentation includes markedly elevated beta-hCG at 150,000 mIU/mL and a classic "snowstorm" ultrasound pattern. The immediate management is a dilation and curettage (D&C) to evacuate the molar tissue. The core of the question asks for the priority nursing intervention in the post-procedural period, shifting the focus from acute recovery to the critical long-term surveillance phase.

Why Contraception is the Priority

The priority intervention is to emphasize the importance of reliable contraception for at least 12 months. This is not merely about family planning; it is a critical component of oncologic surveillance. The primary rationale is the risk of developing gestational trophoblastic neoplasia (GTN), a malignant transformation that can occur after a molar pregnancy, including invasive mole and choriocarcinoma ^[2].

After a D&C for a CHM, the standard of care involves serial monitoring of serum beta-hCG levels until they normalize and for a specified period thereafter. A new pregnancy during this monitoring window produces its own beta-hCG, which is physiologically indistinguishable from the beta-hCG produced by malignant trophoblastic tissue. A rising beta-hCG level is the most sensitive and earliest indicator of post-molar GTN . If a patient becomes pregnant, the cause of a rising beta-hCG level becomes ambiguous, potentially masking the development of a highly curable but aggressive malignancy and leading to a dangerous delay in diagnosis and treatment. The 12-month period of reliable contraception is essential to preserve the diagnostic accuracy of beta-hCG surveillance ^[1].

Analysis of Other Options

While the other interventions are important aspects of holistic nursing care, they do not address the most significant long-term risk and are therefore not the priority.

- Administer prescribed analgesics for post-procedural pain management: Pain management is a standard and important comfort measure following a D&C. However, it addresses an acute, transient symptom and is not the intervention that prevents a potentially life-threatening complication. It is a lower priority than initiating a safety plan for long-term cancer surveillance.
- Monitor vital signs every 4 hours for the first 24 hours: Post-operative monitoring is essential for detecting immediate complications like hemorrhage or infection. However, in a stable patient after an uncomplicated D&C, this is a routine, time-limited task. The question asks for the priority intervention as the patient transitions from acute care to the post-procedural monitoring phase, where the focus shifts to preventing the delayed complication of GTN.
- Provide emotional support regarding pregnancy loss: This is a deeply important and necessary nursing action. A CHM diagnosis involves the loss of a pregnancy and a new cancer-related diagnosis, creating a complex grief response. However, in the NCLEX-RN prioritization framework, an intervention that directly prevents a physiologic threat to the patient's life (masking of malignancy) takes precedence over a psychosocial intervention, even though both are integral to the care plan.

Connecting to the Evidence

The provided literature directly supports this clinical reasoning. The study on contraceptive practices during post-molar monitoring highlights the real-world challenges and critical importance of preventing pregnancy during the beta-hCG surveillance period, as this monitoring is the cornerstone of post-molar care ^[1]. The case reports of invasive mole and recurrent GTN vividly illustrate the reality of malignant transformation after a molar pregnancy, reinforcing why the detection of a rising beta-hCG level through unconfounded monitoring is non-negotiable for patient safety [2, 4]. The clinical priority is to establish a system that allows for the earliest possible detection of GTN, which is achieved by strict pregnancy prevention and serial beta-hCG follow-up.